Well, here’s some good news for a change. A new drug, acoziborole, has been approved as a new, single-dose, oral treatment for T.b. gambiense sleeping sickness. More effective against different disease stages and has a much better side effect profile:
https://www.npr.org/2026/03/16/g-s1-113246/sleeping-sickness-drug-treatment-tsetse-fly
https://dndi.org/research-development/portfolio/acoziborole/
